27-hydroxycholesterol has been researched along with Fatty Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bast, A; Bieghs, V; Gijbels, M; Guichot, YD; Hendrikx, T; Hofker, MH; Jeurissen, ML; Kalhan, SC; Koek, GH; Leitersdorf, E; Lütjohann, D; Plat, J; Rensen, SS; Shiri-Sverdlov, R; van Gorp, PJ; Verheyen, F; Walenbergh, SM | 1 |
1 other study(ies) available for 27-hydroxycholesterol and Fatty Liver
| Article | Year |
|---|---|
The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice.
Topics: Alanine Transaminase; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Bone Marrow Transplantation; Cholestanetriol 26-Monooxygenase; Cholesterol, Dietary; Dietary Fats; Fatty Liver; Female; Foam Cells; Gene Expression; Hepatitis; Humans; Hydroxycholesterols; Kupffer Cells; Lipids; Lipoproteins; Liver; Liver X Receptors; Lysosomes; Male; Mice; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Orphan Nuclear Receptors; Receptors, LDL; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2013 |